International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 2465-2470
Original Article
Optimizing Post-Mastectomy Recovery: Reducing Seroma Formation with the GELFOAM Technique
 ,
 ,
Received
June 10, 2026
Accepted
July 13, 2026
Published
July 24, 2026
Abstract

Background: Breast cancer has consistently been the second leading cause of cancer-related deaths among women globally for the past three decades, significantly contributing to the surgical load associated with cancer treatment. Surgical options for breast cancer include breast conservation therapy and mastectomy, with or without axillary dissection, depending on the stage of the disease. The most common surgical procedure for this cancer is modified radical mastectomy (MRM), which often leads to complications such as skin flap necrosis, hematoma, seroma, and surgical site infection. These postoperative complications can demoralize patients and potentially delay adjuvant treatments, leading to adverse outcomes.

Methods: This prospective analytical study aimed to investigate the efficacy of using GELFOAM to reduce seroma formation post-MRM. Conducted at Pt. J.N.M. Medical College & Dr. B.R.A.M. Hospital, Raipur, Chhattisgarh, from December 2022 to January 2023, the study included 38 patients undergoing MRM. All patients received GELFOAM during surgery, and postoperative follow-ups were conducted on days 2, 7, 14, and 30 to monitor seroma formation and other complications.

Results: The study revealed that 29 patients experienced a reduction in seroma volume, while 9 patients had an increase despite the use of GELFOAM. Significant associations with seroma formation were observed for smoking, hypertension, BMI, and neoadjuvant chemotherapy/radiation (P=0.0001 each), as well as for diabetes mellitus and dense breast tissue (P=0.044 and P=0.040, respectively). The extent of lymph node dissection also played a crucial role, with a highly significant association (P=0.00001). Flap necrosis and surgical site infections were strongly associated with seroma formation (P=0.0001). Early removal of drains and shorter hospital stays were linked to less seroma formation (P=0.00001).

Conclusion: Utilizing GELFOAM during MRM significantly reduces the occurrence and volume of seroma formation, facilitating early removal of suction drains and improving postoperative outcomes. Therefore, incorporating GELFOAM as a standard step in MRM is highly recommended.

Keywords
Recommended Articles
Original Article Open Access
A STUDY ON ATTITUDE OF MOTHERS ABOUT IMMUNIZATION PRACTICES IN GOVERNMENT DISTRICT HOSPITAL KALABURAGI
2026, Volume-7, Issue 4 : 2456-2459
Research Article Open Access
Comparison of Postoperative Outcome in Laparoscopic Versus Open Cholecystectomy in Diabetic Patients
2026, Volume-7, Issue 4 : 2435-2441
Original Article Open Access
A STUDY TO ASSESS THE IMMUNIZATION PRACTICES AMONG MOTHERS ATTENDING THE GOVERNMENT DISTRICT HOSPITAL KALABURAGI
2026, Volume-7, Issue 4 : 2460-2464
Research Article Open Access
A Study of the Anatomical Variations of the Circle of Willis in Adult Human Brains
2026, Volume-7, Issue 4 : 2426-2434
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
5 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved